HALB Halberd Corp.

Halberd Announces Agreement to Retire 192,000,000 Outstanding Common Shares and Acquisition/Joint Venture to Be Announced, in Detail, This Week

Lake Charles, Louisiana--(Newsfile Corp. - April 6, 2020) - Halberd Corporation (OTC Pink: HALB) announces that it has reached an agreement with shareholders holding 192,000,000 shares of the 482,838,125 reported as currently outstanding. Those shares will be returned to treasury and retired. We are also reducing the authorized shares of common stock to 1,000,000,000.

Mr. LeDoux, the new CEO, explained that "perhaps even before becoming compliant with our reporting obligations with OTCMarkets, within the next few days, we will detail the transaction which will drive Halberd's future."

Safe Harbor Statement: This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Such statements include any that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "likely", "should", "could", "would", "may" or similar words or expressions. Such statements are not a guarantee of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those in such statements, which involve risks and uncertainties, including those relating to the Company's ability to grow. Actual results may differ materially from those predicted and any reported should not be considered an indication of future performance. Potential risks and uncertainties include the Company's operating history and resources, economic, competitive, and equity market conditions.

James Christopher LeDoux, CEO
Halberd Corporation
Email Contact:

Twitter:

To view the source version of this press release, please visit

EN
06/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Halberd Corp.

 PRESS RELEASE

Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clini...

Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates Issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease JACKSON CENTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease. ...

 PRESS RELEASE

Progress Update on Halberd, Athena GTX and Athena Telemedicine Partner...

Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award! JACKSON CENTER, Pa., March 17, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) partnered with Athena GTX on a profit-sharing agreement over a year ago. This enabled Halberd to utilize Athena’s expertise and experience in dealing with the federal government. Of the two technologies associated with Traumatic Brain Injuries (TBI)/Suicide Ideation for which we chose to pursue government funding, Athena’s s...

 PRESS RELEASE

Halberd Update on WatchDawg® PTSD Treatment

Halberd Update on WatchDawg® PTSD Treatment Next Phase Pilot Study JACKSON CENTER, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found . Based on the encouraging results of that initial pilot study, upgrades and enhancements to the data collection methodology, data analysis, hardware, software performance and reporting improvements have been incorporated into future studi...

 PRESS RELEASE

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatme...

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System JACKSON CENTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veterans participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wr...

 PRESS RELEASE

Halberd Partnership Secures Contract from Defense Atomics Corporation ...

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI JACKSON CENTER, Pa., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB), in coordination with Athena Telemedicine Partners (ATP) and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with the Halberd/Athena teams and to fund key advanced research, including the pending FDA IND study utilizing Halberd’s LDX techno...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch